{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:40:05Z","timestamp":1748583605706,"version":"3.41.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hokkaido Heart Association"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10157-025-02625-8","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T11:10:48Z","timestamp":1737371448000},"page":"777-787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glomerular diameter is associated with a reduction in urinary protein by treatment with dapagliflozin in patients with chronic kidney disease"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9574-0302","authenticated-orcid":false,"given":"Arata","family":"Osanami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufu","family":"Gocho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marenao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"issue":"5","key":"2625_CR1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","volume":"96","author":"KJ Jager","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96(5):1048\u201350.","journal-title":"Kidney Int"},{"issue":"5","key":"2625_CR2","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ki.2015.230","volume":"88","author":"KT Mills","year":"2015","unstructured":"Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950\u20137.","journal-title":"Kidney Int"},{"issue":"9731","key":"2625_CR3","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073\u201381.","journal-title":"Lancet"},{"issue":"22","key":"2625_CR4","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2012.16817","volume":"308","author":"SI Hallan","year":"2012","unstructured":"Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA. 2012;308(22):2349\u201360.","journal-title":"JAMA"},{"issue":"2","key":"2625_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030131","volume":"13","author":"JI Barzilay","year":"2024","unstructured":"Barzilay JI, Farag YMK, Durthaler J. Albuminuria: An underappreciated risk factor for cardiovascular disease. J Am Heart Assoc. 2024;13(2): e030131.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"2625_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S2213-8587(18)30314-0","volume":"7","author":"HJL Heerspink","year":"2019","unstructured":"Heerspink HJL, Greene T, Tighiouart H, Gansevoort RT, Coresh J, Simon AL, et al. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. Lancet Diabetes Endocrinol. 2019;7(2):128\u201339.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"15","key":"2625_CR7","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436\u201346.","journal-title":"N Engl J Med"},{"issue":"2","key":"2625_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"WG Herrington","year":"2023","unstructured":"Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"2","key":"2625_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/ndt\/gfad175","volume":"39","author":"F Caravaca-Font\u00e1n","year":"2024","unstructured":"Caravaca-Font\u00e1n F, Stevens K, Padr\u00f3n M, Huerta A, Montomoli M, Villa J, et al. Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis. Nephrol Dial Transplant. 2024;39(2):328\u201340.","journal-title":"Nephrol Dial Transplant"},{"issue":"18","key":"2625_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016976","volume":"9","author":"SW Waijer","year":"2020","unstructured":"Waijer SW, Xie D, Inzucchi SE, Zinman B, Koitka-Weber A, Mattheus M, et al. Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial. J Am Heart Assoc. 2020;9(18): e016976.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"2625_CR11","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1681\/ASN.2020050723","volume":"31","author":"M Oshima","year":"2020","unstructured":"Oshima M, Neuen BL, Li J, Perkovic V, Charytan DM, de Zeeuw D, et al. Early change in albuminuria with canagliflozin predicts kidney and cardiovascular outcomes: A PostHoc Analysis from the CREDENCE Trial. J Am Soc Nephrol. 2020;31(12):2925\u201336.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2625_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S2213-8587(21)00243-6","volume":"9","author":"N Jongs","year":"2021","unstructured":"Jongs N, Greene T, Chertow GM, McMurray JJV, Langkilde AM, Correa-Rotter R, et al. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol. 2021;9(11):755\u201366.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2625_CR13","doi-asserted-by":"publisher","first-page":"C661","DOI":"10.1152\/ajpcell.00177.2023","volume":"325","author":"X Chen","year":"2023","unstructured":"Chen X, Hocher CF, Shen L, Kr\u00e4mer BK, Hocher B. Reno- and cardioprotective molecular mechanisms of SGLT2 inhibitors beyond glycemic control: from bedside to bench. Am J Physiol Cell Physiol. 2023;325(3):C661\u201381.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"2625_CR14","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/ki.1996.265","volume":"49","author":"BM Brenner","year":"1996","unstructured":"Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 1996;49(6):1774\u20137.","journal-title":"Kidney Int"},{"issue":"24","key":"2625_CR15","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMoa1614329","volume":"376","author":"A Denic","year":"2017","unstructured":"Denic A, Mathew J, Lerman LO, Lieske JC, Larson JJ, Alexander MP, et al. Single-nephron glomerular filtration rate in healthy adults. N Engl J Med. 2017;376(24):2349\u201357.","journal-title":"N Engl J Med"},{"key":"2625_CR16","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2625_CR17","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","volume":"59","author":"N Kambham","year":"2001","unstructured":"Kambham N, Markowitz GS, Valeri AM, Lin J, D\u2019Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59(4):1498\u2013509.","journal-title":"Kidney Int"},{"issue":"19","key":"2625_CR18","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.csbj.2021.01.022","volume":"21","author":"MP Humphries","year":"2021","unstructured":"Humphries MP, Maxwell P, Salto-Tellez M. QuPath: The global impact of an open source digital pathology system. Comput Struct Biotechnol J. 2021;21(19):852\u20139.","journal-title":"Comput Struct Biotechnol J"},{"key":"2625_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2625_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.118.037418","volume":"140","author":"K Kidokoro","year":"2019","unstructured":"Kidokoro K, Cherney DZI, Bozovic A, Nagasu H, Satoh M, Kanda E, et al. Evaluation of glomerular hemodynamic function by empagliflozin in diabetic mice using in vivo imaging. Circulation. 2019;140(4):303\u201315.","journal-title":"Circulation"},{"issue":"6","key":"2625_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","volume":"16","author":"V Vallon","year":"2020","unstructured":"Vallon V, Thomson SC. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat Rev Nephrol. 2020;16(6):317\u201336.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"2625_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrneph.2012.19","volume":"8","author":"I Helal","year":"2012","unstructured":"Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 2012;8(5):293\u2013300.","journal-title":"Nat Rev Nephrol"},{"issue":"3 Pt 2","key":"2625_CR23","first-page":"F495","volume":"258","author":"SA Brown","year":"1990","unstructured":"Brown SA, Finco DR, Crowell WA, Choat DC, Navar LG. Single-nephron adaptations to partial renal ablation in the dog. Am J Physiol. 1990;258(3 Pt 2):F495-503.","journal-title":"Am J Physiol"},{"issue":"7","key":"2625_CR24","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1681\/ASN.2014040328","volume":"26","author":"X Wang","year":"2015","unstructured":"Wang X, Johnson AC, Williams JM, White T, Chade AR, Zhang J, et al. Nephron deficiency and predisposition to renal injury in a novel one-kidney genetic model. J Am Soc Nephrol. 2015;26(7):1634\u201346.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2625_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/bph.12269","volume":"170","author":"T Nagata","year":"2013","unstructured":"Nagata T, Fukuzawa T, Takeda M, Fukazawa M, Mori T, Nihei T, et al. Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db\/db mice. Br J Pharmacol. 2013;170(3):519\u201331.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"2625_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1124\/jpet.113.203869","volume":"345","author":"N Kojima","year":"2013","unstructured":"Kojima N, Williams JM, Takahashi T, Miyata N, Roman RJ. Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats. J Pharmacol Exp Ther. 2013;345(3):464\u201372.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"2625_CR27","doi-asserted-by":"publisher","first-page":"C951","DOI":"10.1152\/ajpcell.00528.2022","volume":"324","author":"X Chen","year":"2023","unstructured":"Chen X, Deli\u0107 D, Cao Y, Shen L, Shao Q, Zhang Z, et al. Renoprotective effects of empagliflozin are linked to activation of the tubuloglomerular feedback mechanism and blunting of the complement system. Am J Physiol Cell Physiol. 2023;324(4):C951\u201362.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"2625_CR28","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1093\/ndt\/gfr139","volume":"26","author":"H Kataoka","year":"2011","unstructured":"Kataoka H, Ohara M, Honda K, Mochizuki T, Nitta K. Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy. Nephrol Dial Transplant. 2011;26(12):3937\u201343.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2625_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000515528","volume":"46","author":"R Zamami","year":"2021","unstructured":"Zamami R, Kohagura K, Kinjyo K, Nakamura T, Kinjo T, Yamazato M, et al. The Association between Glomerular Diameter and Secondary Focal Segmental Glomerulosclerosis in Chronic Kidney Disease. Kidney Blood Press Res. 2021;46(4):433\u201340.","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"2625_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0272-6386(12)80483-5","volume":"17","author":"M Praga","year":"1991","unstructured":"Praga M, Borstein B, Andres A, Arenas J, Oliet A, Montoyo C, et al. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis. 1991;17(3):330\u20138.","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02625-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:20:00Z","timestamp":1748582400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02625-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2625"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02625-8","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of this manuscript have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study conformed to the principles outlined in the Declaration of Helsinki and was performed with the approval of the institutional ethical committee of Sapporo Medical University (Number: 352\u2013152).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}